Close
Close

Melissa P. Wasserstein, MD, Chief of Pediatric Genetic Medicine at the Children's Hospital at Montefiore, New York City discusses Niemann–Pick diseases, a subgroup of lipid storage disorders called sphingolipidoses in which harmful quantities of fatty substances, or lipids, accumulate in the spleen, liver, lungs, bone marrow, and brain. In the classic infantile type-A variant, a missense mutation causes complete deficiency of sphingomyelinase. Dr. Wasserstein is an NIH-funded clinical researcher whose work focuses on evaluating the safety and effectiveness of novel treatments for patients with inborn errors of metabolism. Prior to joining CHAM, Dr. Wasserstein was Director of the Program for Inherited Metabolic Diseases at Mount Sinai Health System.

by Scott Harwood
10 views 1 week ago
by Abidemi Uruejoma
41 views 2 weeks ago
by Scott Harwood
24 views 2 weeks ago
by Abidemi Uruejoma
66 views 3 weeks ago
by Scott Harwood
66 views 1 month ago
1.5
1.5 from 2 votes
Free Newsletter
Find a Clinical Trial
Related Videos
by Scott Harwood
155 views
by Abidemi Uruejoma
261 views
by Abidemi Uruejoma
10,158 views